2. Search Result
Search Result
Results for "

H-8

" in MedChemExpress (MCE) Product Catalog:

6

Inhibitors & Agonists

1

Biochemical Assay Reagents

1

Inhibitory Antibodies

4

Recombinant Proteins

1

Antibodies

1

Oligonucleotides

Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-112465
    H-8 dihydrochloride

    		PKA Cancer
    H-8 (dihydrochloride) is a cell-permeable, reversible and ATP-competitive PKA inhibitor .
    H-8 dihydrochloride
  • HY-W040188
    Fosfructose trisodium octahydrate

    		Biochemical Assay Reagents Others
    FdPNa3H·8H2O (Harden-Young ester) is a biochemical reagent that can be used as a biological material or organic compound for life science related research.
    Fosfructose trisodium octahydrate
  • HY-P99620
    Firivumab

    CT-P22; CT120

    		 Influenza Virus Infection
    Firivumab (CT-P22; CT120) is a human IgG1 monoclonal influenza A virus hemagglutinin (Anti-IAV HA) antibody. Firivumab is capable of neutralizing H1N1, H5N1, H6N1, H6N2, H8N4, H8N8, H9N2 and H12N7. Firivumab shows protection against H1N1 virus in mice .
    Firivumab
  • HY-117093
    H8-A5

    		Others Cancer
    H8-A5 is a novel human histone deacetylase 8 (HDAC8) inhibitor. A highly specific ZBG-based pharmacophore model was developed by incorporating a custom zinc-binding group (ZBG) feature. Pharmacophore-based virtual screening identified three novel HDAC8 inhibitors with low micromolar IC50 values (1.8-1.9 μM). Further studies showed that H8-A5 was more selective for HDAC8 than HDAC1/4 and exhibited antiproliferative activity in MDA-MB-231 cancer cells. Molecular docking and molecular dynamics studies showed that H8-A5 could bind to HDAC8, providing a good starting point for the development of HDAC8 inhibitors for cancer treatment.
    H8-A5
  • HY-RS15996
    ZC3H8 Human Pre-designed siRNA Set A

    		Small Interfering RNA (siRNA) Others

    ZC3H8 Human Pre-designed siRNA Set A contains three designed siRNAs for ZC3H8 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

    ZC3H8 Human Pre-designed siRNA Set A
    ZC3H8 Human Pre-designed siRNA Set A
  • HY-164123
    Antibiofilm agent-9

    		Bacterial Infection
    Antibiofilm agent-9 (Compound 4) is a pyrrolomycin derivative with antibacterial activity. Antibiofilm agent-9 inhibits Bacillus anthracis with MIC of 0.031 μg/mL. Antibiofilm agent-9 exhibits antibiofilm activity with 84% biofilm inhibition (24 h, 8.0 μg/mL). Antibiofilm agent-9 exhibits a good pharmacokinetic characters in mouse model .
    Antibiofilm agent-9

Inquiry Online

Your information is safe with us. * Required Fields.

Salutation

  

Country or Region *

Applicant Name *

 

Organization Name *

Department *

     

Email Address *

 

Product Name *

Cat. No.

  

Requested quantity *

Phone Number *

     

Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: